CK2/ERK8-IN-1 |
Catalog No.GC39485 |
CK2/ERK8-IN-1은 IC50이 0.50μM인 이중 카제인 키나제 2(CK2)(Ki 0.25μM) 및 ERK8(MAPK15, ERK7) 억제제입니다. CK2/ERK8-IN-1은 또한 각각 8.65μM, 15.25μM 및 11.9μM의 Kis로 PIM1, HIPK2(호메오도메인 상호작용 단백질 키나제 2) 및 DYRK1A에 결합합니다. CK2/ERK8-IN-1은 세포자멸사 효능이 있습니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1085822-09-8
Sample solution is provided at 25 µL, 10mM.
CK2/ERK8-IN-1 is a dual casein kinase 2 (CK2) (Ki of 0.25 µM) and ERK8 inhibitor with IC50s of 0.50 μM. CK2/ERK8-IN-1 also binds to PIM1, HIPK2 (homeodomain-interacting protein kinase 2), and DYRK1A with Kis of 8.65 µM, 15.25 µM, and 11.9 µM, respectively. CK2/ERK8-IN-1 has pro-apoptotic efficacy[1].
[1]. Pagano MA, et al. The selectivity of inhibitors of protein kinase CK2: an update. Biochem J. 2008 Nov 1;415(3):353-65.
Average Rating: 5
(Based on Reviews and 1 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *